On 09 May 2018
Jubilant Life Sciences will hold a meeting of the Board of Directors of the Company on 09 May 2018, to inter-alia consider Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018, and recommendation of Dividend for the Financial Year ended March 31, 2018.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)